Working... Menu
Trial record 37 of 132 for:    "Paroxysmal Ventricular Fibrillation"

Septal Positioning of Ventricular Implanted Cardioverter Defibrillator (ICD) Leads (SPICE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00745745
Recruitment Status : Completed
First Posted : September 3, 2008
Last Update Posted : February 4, 2019
Information provided by (Responsible Party):
Abbott Medical Devices

Brief Summary:
This clinical trial is a multi center, prospective, randomized, parallel study designed to compare septal to apical ICD lead placement.

Condition or disease Intervention/treatment Phase
Ventricular Tachycardia Ventricular Fibrillation Device: Device Implantation Not Applicable

Detailed Description:
The primary objective of this clinical investigation is to demonstrate that septal positioning of the right ventricular defibrillation lead is not inferior to the apical positioning in terms of safety and efficacy in a population of ICD recipients.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 299 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Septal Positioning of Ventricular ICD Leads
Study Start Date : August 2008
Actual Primary Completion Date : June 2011
Actual Study Completion Date : January 2013

Arm Intervention/treatment
Active Comparator: 1
Apical ICD lead placement
Device: Device Implantation
ICD lead implantation
Other Names:
  • CE marked ICD/CRT-D from St. Jude Medical and compatible CE marked ICD- and
  • pacemaker- and active fixation ICD-leads

Experimental: 2
Mid-Septal ICD lead placement
Device: Device Implantation
ICD lead implantation
Other Names:
  • CE marked ICD/CRT-D from St. Jude Medical and compatible CE marked ICD- and
  • pacemaker- and active fixation ICD-leads

Primary Outcome Measures :
  1. Event free survival of RV-ICD-lead related complications [ Time Frame: 3 months after implantation ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age >=18 years
  • Signed written informed consent
  • Approved indication for implantation of ICD / CRT-D device

Exclusion Criteria:

  • Preexisting transvenous RV pacemaker or ICD leads
  • Pacemaker dependency without sufficient intrinsic rhythm (≤ 30min-1)
  • Hypertrophic obstructive cardiomyopathy
  • Presence of intra-aortic balloon pump
  • Inotropic drug (not digitalis) necessary for hemodynamic support
  • Inability to perform VF induction testing due to anticipated high risk
  • Condition likely to limit cooperation
  • Unable to give informed consent
  • Pregnancy or planned pregnancy in the next 6 months
  • Patients with planned cardiac surgery within the next 3 months following randomization
  • Patient is currently participating in a clinical investigation that includes an active treatment arm.
  • Acute myocardial infarction within the previous 4 weeks.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00745745

Layout table for location information
Ost-Alb Klinikum
Aalen, Germany, 73430
SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald
Bad Friedrichshall, Germany, 74177
Segeberger Kliniken GmbH
Bad Segeberg, Germany, 23795
Städtisches Klinikum Brandenburg
Brandenburg, Germany, 14770
Medizinisches Versorgungszentrum
Dachau, Germany, 85221
Krankenhaus Düren gGmbH Akademisches Lehrkrankenhaus der RWTH-Aachen
Düren, Germany, 52351
Klinikum Esslingen
Esslingen, Germany, 73730
Universitätsklinik Freiburg
Freiburg, Germany, 79106
Herzkatheterlabor der Kardiologischen Praxis am Krankenhaus Neu-Bethlehem gGmbH
Göttingen, Germany, 37073
Asklepios Klinik St. Georg
Hamburg, Germany, 20099
Oberhavel Kliniken GmbH Klinik Hennigsdorf
Hennigsdorf, Germany, 16761
Krankenhaus Landshut-Achdorf
Landshut, Germany, 84036
Universitätsklinikum Leipzig AÖR
Leipzig, Germany, 04103
Kliniken Ludwigsburg-Bietigheim
Ludwigsburg, Germany, 71640
Märkische Kliniken GmbH Klinikum Lüdenscheid
Luedenscheid, Germany, 58515
Klinikum Mannheim gGmbH Fakultät für Klinische Medizin Mannheim der Universität Heidelberg
Mannheim, Germany, 68167
Deutsches Herzzentrum Muenchen
Munich, Germany, 80636
Maria-Hilf Franziskus-Krankenhaus
Mönchengladbach, Germany, 41063
Niels-Stensen-Kliniken Marienhospital Osnabrück
Osnabrück, Germany, 49074
Klinkum Peine gGmbH
Peine, Germany, 31228
Henry Dunant Hospital
Athens, Greece, 11526
Sponsors and Collaborators
Abbott Medical Devices
Layout table for investigator information
Principal Investigator: Christoph Kolb, MD Deutsches Herzzentrum München des Freistaates Bayern

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Abbott Medical Devices Identifier: NCT00745745     History of Changes
Other Study ID Numbers: T83
First Posted: September 3, 2008    Key Record Dates
Last Update Posted: February 4, 2019
Last Verified: February 2019

Additional relevant MeSH terms:
Layout table for MeSH terms
Tachycardia, Ventricular
Ventricular Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Cardiac Conduction System Disease
Pathologic Processes